Search

Your search keyword '"Munshi, Nikhil C"' showing total 2,771 results

Search Constraints

Start Over You searched for: Author "Munshi, Nikhil C" Remove constraint Author: "Munshi, Nikhil C" Search Limiters Full Text Remove constraint Search Limiters: Full Text
2,771 results on '"Munshi, Nikhil C"'

Search Results

2. Author Correction: The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells

3. Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies

4. Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

5. Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma

9. Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

11. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma

12. CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma

13. High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

15. A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth

18. Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma

19. Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH

20. Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia

26. Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia

27. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

30. Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3′-Kinase/AKT Signaling

31. Retraction: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications

32. Retraction: Nuclear Factor-κB p65 Mediates Tumor Necrosis Factor α-induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein

35. Abstract P24: GABARAP deficiency drives resistance to immunogenic chemotherapy in multiple myeloma

36. Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

37. Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts)

38. Biomarker Correlates of 3 Year Response in Cartitude-1: A Phase 1b/2 Open-Label Study of Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma

40. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

42. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability

46. Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells

47. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs

48. Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis

49. ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma

50. Differentiation of BCMA-specific induced pluripotent stem cells into CD8ab+ T cells targeting myeloma

Catalog

Books, media, physical & digital resources